ArticleThe journal of headache and pain2025
Impact of migraine on productivity and efficiency among adult population in India: a scoping review.
Article in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Knowledge, Attitude, and Practices of General Neurologists and Headache Experts Toward Migraine Treatment: A Cross-Sectional Study in India.Annals of Indian Academy of Neurology · 2026Article
- Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.The journal of headache and pain · 2026Observational
- The relationship between impulsivity and decision-making styles in individuals with episodic migraine.Frontiers in neurology · 2026Article
- Trends in the Disease Burden of Migraine Among Women of Reproductive Age (15-49 Years) in Low- and Middle-Income Countries, 1990-2023.International journal of women's health · 2026Article
- Association between psychological disorders and migraine in young U.S. adults with gender-specific analysis and marital status considerations.The journal of headache and pain · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMigraine is a common neurological disorder that has a major negative influence on productivity loss and quality of life. Significant socioeconomic consequences are associated with the condition, such as decreased productivity at work and increased medical expenses. The frequency is higher in women, especially in reproductive age, and the burden varies globally. In India, the prevalence of migraine is 25%; this is higher than the global prevalence of 14.7%. The scoping review is undertaken with an aim to synthesize existing literature that summarizes the impact of migraine on productivity among working professionals, with a focus on its determinants in India.
methodsA systematic scoping review, with a comprehensive search strategy, was conducted across major databases. Eligibility criteria for studies to be included focused on prevalence, economic and observational studies involving adults aged 18 and older diagnosed with migraines. Studies conducted from January 2014 to October 2024 in Low- and Middle-Income Countries (LMICs) were included. Data extraction was standardized, capturing key study characteristics. The methodological quality of included studies was assessed using the JBI score checklist for the assessment of cross-sectional and prevalence studies. The pooled estimates for productivity loss were collated from individual studies and adjusted per capita national income. This pooled productivity loss was used to estimate the per day economic loss based on per capita income.
resultsThe systematic search identified 11 relevant articles for LMICs that provided insights into the impact of migraines on productivity and economic outcomes. The evidence highlighted that migraine-related productivity losses ranged from 3% to 4.3% of productive time, translating to significant financial implications. Evidence from India suggests one-year prevalence of migraines is approximately 14.12% to 28.99%, affecting around 213 million cases annually. The pooled analysis obtained from two studies shows that productivity loss due to migraine is 17.3 days per year. This was found to be INR 8731/- annually based on daily per capita income. Taking the prevalence of migraine in India, it leads to a total economic loss of about INR 18,674.35 crore (approximately USD 22.21 billion). This significant burden emphasizes the urgent need for effective healthcare interventions to address and manage migraine disorders in the population.
conclusionMigraines impose a significant threat to the economy and productivity in India, especially for working professionals and women in their prime working years. Addressing migraine as a public health priority through awareness, early diagnosis, and effective management will not only improve quality of life but also enhance national productivity and economic growth of the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.